Internal Medicine, Medical Oncology · Gulfport, MS
NPI
1518348978
Since 2015
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1340 Broad Ave Ste 270
Gulfport, MS, 39501
Phone (228) 575-1234
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
1,165 services
Medicare patients, 2024
311
Average age 74
Drug cost, 2024
$1.8M
2,499 prescriptions
Company payments, 2025
$4,155
From 45 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sidra Khalid was code 99215 (office e&m - established), 376 times for 69 patients. In total Sidra Khalid billed 1,165 services in 17 codes, and Medicare paid $108K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 376 | 69 | $111.95 | $42K |
| 99214 Office E&M - Established | Facility | 335 | 164 | $74.80 | $25K |
| 99233 Hospital E&M - Subsequent | Facility | 201 | 74 | $93.73 | $19K |
| 99222 Hospital E&M - Initial | Facility | 52 | 45 | $98.35 | $5,114 |
| 99223 Hospital E&M - Initial | Facility | 49 | 43 | $132.29 | $6,482 |
| 99213 Office E&M - Established | Facility | 40 | 33 | $52.13 | $2,085 |
| 99214 Office E&M - Established | Office | 31 | 24 | $61.80 | $1,916 |
| 99215 Office E&M - Established | Office | 27 | 21 | $99.85 | $2,696 |
| 99204 Office E&M - New | Facility | 19 | 19 | $105.40 | $2,003 |
By year: 2022 $96K for 1,065 services; 2023 $94K for 1,060 services; 2024 $108K for 1,165 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sidra Khalid prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 182 prescriptions and refills. In total Sidra Khalid wrote 2,499 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 182 | 182 | 49 | $3,607 |
| Oxycodone Hcl Generic | 182 | 184 | 29 | $3,254 |
| Prednisone Generic | 134 | 134 | 45 | $364 |
| Pantoprazole Sodium Generic | 92 | 196 | 39 | $806 |
| Ondansetron Hcl Generic | 78 | 78 | 43 | $3,238 |
| Alprazolam Generic | 72 | 72 | 22 | $303 |
| Anastrozole Generic | 68 | 138 | 18 | $953 |
| Gabapentin Generic | 66 | 93 | 22 | $381 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 63 | 63 | 45 | $798 |
| Levothyroxine Sodium Generic | 59 | 69 | 15 | $386 |
| Famotidine Generic | 57 | 113 | 31 | $532 |
| Abiraterone Acetate Generic | 54 | 54 | 11 | $49K |
| Dexamethasone Generic | 54 | 54 | 30 | $634 |
| Megestrol Acetate Generic | 51 | 63 | 20 | $2,086 |
| Potassium Chloride Generic | 40 | 46 | 20 | $256 |
Brand drugs: - claims; generic drugs: 2,128 claims; opioid claims: 495.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sidra Khalid $4,155 ($4,155 in general payments such as food, travel and fees) from 45 companies. The largest payer was Merck Sharp & Dohme LLC with $329.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 16 | $329 |
| Janssen Biotech, Inc. JNJ | 16 | $315 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $247 |
| Daiichi Sankyo Inc. 4568.T | 13 | $224 |
| Gilead Sciences, Inc. GILD | 7 | $185 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $180 |
| Pfizer Inc. PFE | 11 | $174 |
| TerSera Therapeutics LLC | 6 | $172 |
| Genmab U.S., Inc. GMAB | 4 | $166 |
| Astellas Pharma US Inc 4503.T | 6 | $159 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.